| Alfred Swanson, MD | |
|
4320 Diplomacy Dr, Anchorage, AK 99508-5925 | |
| (907) 729-3300 | |
| Not Available |
| Full Name | Alfred Swanson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932550738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 174222 (Alaska) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
While not a new problem, the spread of misinformation throughout the coronavirus disease 2019 (COVID-19) pandemic has exploded on almost every social media platform. Recently, a group of researchers analyzed conversations on public Facebook groups to explored automated misinformation on mask-wearing. The team published their findings as a research letter in the JAMA Internal Medicine journal.
Wintherix, LLC, a privately held biotechnology company focusing on bone healing and regenerative medicine, today announced that WX04554, a potent small molecule activator of the Wnt pathway, has been designated as a lead drug for clinical development in bone healing and repair indications.
Johns Hopkins cancer scientists have discovered that a little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis, and the scientists' research suggests that mutations in the gene may contribute to commonly found chromosomal instability in cancer.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
› Verified 8 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
While not a new problem, the spread of misinformation throughout the coronavirus disease 2019 (COVID-19) pandemic has exploded on almost every social media platform. Recently, a group of researchers analyzed conversations on public Facebook groups to explored automated misinformation on mask-wearing. The team published their findings as a research letter in the JAMA Internal Medicine journal.
Wintherix, LLC, a privately held biotechnology company focusing on bone healing and regenerative medicine, today announced that WX04554, a potent small molecule activator of the Wnt pathway, has been designated as a lead drug for clinical development in bone healing and repair indications.
Johns Hopkins cancer scientists have discovered that a little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis, and the scientists' research suggests that mutations in the gene may contribute to commonly found chromosomal instability in cancer.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
› Verified 8 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
While not a new problem, the spread of misinformation throughout the coronavirus disease 2019 (COVID-19) pandemic has exploded on almost every social media platform. Recently, a group of researchers analyzed conversations on public Facebook groups to explored automated misinformation on mask-wearing. The team published their findings as a research letter in the JAMA Internal Medicine journal.
Wintherix, LLC, a privately held biotechnology company focusing on bone healing and regenerative medicine, today announced that WX04554, a potent small molecule activator of the Wnt pathway, has been designated as a lead drug for clinical development in bone healing and repair indications.
Johns Hopkins cancer scientists have discovered that a little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis, and the scientists' research suggests that mutations in the gene may contribute to commonly found chromosomal instability in cancer.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alfred Swanson, MD 4320 Diplomacy Dr Ste 2300, Anchorage, AK 99508-5925 Ph: (907) 729-3300 | Alfred Swanson, MD 4320 Diplomacy Dr, Anchorage, AK 99508-5925 Ph: (907) 729-3300 |
News Archive
While not a new problem, the spread of misinformation throughout the coronavirus disease 2019 (COVID-19) pandemic has exploded on almost every social media platform. Recently, a group of researchers analyzed conversations on public Facebook groups to explored automated misinformation on mask-wearing. The team published their findings as a research letter in the JAMA Internal Medicine journal.
Wintherix, LLC, a privately held biotechnology company focusing on bone healing and regenerative medicine, today announced that WX04554, a potent small molecule activator of the Wnt pathway, has been designated as a lead drug for clinical development in bone healing and repair indications.
Johns Hopkins cancer scientists have discovered that a little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis, and the scientists' research suggests that mutations in the gene may contribute to commonly found chromosomal instability in cancer.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
› Verified 8 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |